Home Articles List Article Information
ALEXMED ePosters
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Dawood, M. (2020). EFFICACY AND SAFETY OF MICROPULSE TRANSSCERAL DIODE CYCLOPHOTOCOAGULATION IN PATIENTS WITH GLAUCOMA. ALEXMED ePosters, 2(2), 66-66. doi: 10.21608/alexpo.2020.50906.1075
Mohamad Rezk Dawood. "EFFICACY AND SAFETY OF MICROPULSE TRANSSCERAL DIODE CYCLOPHOTOCOAGULATION IN PATIENTS WITH GLAUCOMA". ALEXMED ePosters, 2, 2, 2020, 66-66. doi: 10.21608/alexpo.2020.50906.1075
Dawood, M. (2020). 'EFFICACY AND SAFETY OF MICROPULSE TRANSSCERAL DIODE CYCLOPHOTOCOAGULATION IN PATIENTS WITH GLAUCOMA', ALEXMED ePosters, 2(2), pp. 66-66. doi: 10.21608/alexpo.2020.50906.1075
Dawood, M. EFFICACY AND SAFETY OF MICROPULSE TRANSSCERAL DIODE CYCLOPHOTOCOAGULATION IN PATIENTS WITH GLAUCOMA. ALEXMED ePosters, 2020; 2(2): 66-66. doi: 10.21608/alexpo.2020.50906.1075

EFFICACY AND SAFETY OF MICROPULSE TRANSSCERAL DIODE CYCLOPHOTOCOAGULATION IN PATIENTS WITH GLAUCOMA

Article 33, Volume 2, Issue 2, October 2020, Page 66-66  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2020.50906.1075
View on SCiNiTO View on SCiNiTO
Author
Mohamad Rezk Dawood email
Ophthalmology department, Faculty of Medicine, University of Alexandria, Resident at ministry of health
Abstract
• Glaucoma is the leading cause of irreversible blindness in the world, with approximately 8.4 million people blind from glaucomaSlowing disease progression and preservation of quality of life are the main goals for glaucoma treatment.
• The only applied proven method to treat glaucoma is the reduction of intraocular pressure
• Current glaucoma therapies include topical and systemic drugs, laser surgery, invasive glaucoma surgeries.
• The new Micropulse Trans scleral Cyclophotocoagulation (MPTSCPC) is a non-incisional, noninvasive LASER treatment for glaucoma
The micropulse delivery mode includes "on" and "off" cycles, allowing energy to build up in the targeted pigmented tissues, eventually reaching the coagulative threshold. The adjacent non-pigmented structures have time to " cool off" during the "off " cycle, thus never reaching the coagulative threshold, which minimizes collateral tissue damage
Aim of work
The aim of this study is to evaluate the efficacy and safety of contact transscleral micropulse diode cyclophotocoagulation in patients with glaucoma.
Keywords
Micropulse Trans scleral Cyclophotocoagulation (MPTSCPC); Cyclophotocoagulation; Diode laser
Statistics
Article View: 152